PEOPLE - Thoratec Laboratories makes appointment:
This article was originally published in Clinica
Executive Summary
Thoratec Laboratories has appointed Daniel Cole to its board of directors. Mr Cole is a general manager of Spray Venture Fund, a healthcare venture capital firm, and also holds directorships in several other US medical device companies, including Cambridge Heart and SurVivaLink.